Sana Biotechnology, Inc.
SANA
$3.55
-$0.12-3.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -211.82M | -241.99M | -244.17M | -234.41M | -252.18M |
| Total Depreciation and Amortization | 10.87M | 11.49M | 12.75M | 13.50M | 14.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.99M | 103.71M | 97.70M | 71.82M | 67.38M |
| Change in Net Operating Assets | -1.28M | -5.76M | -10.11M | -9.26M | -10.30M |
| Cash from Operations | -132.24M | -132.55M | -143.83M | -158.35M | -180.74M |
| Capital Expenditure | -2.82M | -1.09M | -938.00K | -501.00K | -4.55M |
| Sale of Property, Plant, and Equipment | 1.07M | 1.43M | 1.43M | 771.00K | 635.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.85M | -7.74M | -40.73M | 23.08M | 117.06M |
| Cash from Investing | -102.60M | -7.40M | -40.24M | 23.35M | 113.15M |
| Total Debt Issued | -- | -- | -- | -56.00K | 116.00K |
| Total Debt Repaid | -360.00K | -353.00K | -347.00K | -258.00K | -171.00K |
| Issuance of Common Stock | 221.00M | 128.01M | 129.08M | 112.04M | 4.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -36.00K | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 220.64M | 127.62M | 128.73M | 111.73M | 4.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.20M | -12.33M | -55.33M | -23.28M | -63.32M |